TelePharmaceutical Care Diabetes Trial

Status Not yet recruiting

Clinical Trial Summary

The prevalence of Diabetes Mellitus (DM) in the world is currently around 9.3% of adults aged between 20 and 79 years, which corresponds to 463 million people living with DM, and about 80% of these people are found in developing countries. In Brazil, fourth in the number of patients with Type 2 Diabetes Mellitus (DM2) in the world, the prevalence of DM is around 12%, with a significant increase in the last three decades. Non-adherence to DM treatment is known as a problem in the scenario and internationally, as it impairs the physiological response to the disease, increasing the direct and indirect cost of treatment. Pharmaceutical care is a practice model characterized by the provision of pharmaceutical services that optimize treatment, improve the process of medicines used, and aim at their best use. With the calamity situation arising from the COVID-19 pandemic created in the state of Rio Grande do Sul, the Pharmaceutical Telecare service was implemented. Dapagliflozin was recently incorporated into the Brazilian public system for the treatment of type 2 DM. Considering that there are no studies in Brazil to date on the use, treatment adherence, and problems related to pharmacotherapy (PRM) associated with dapagliflozin, and also considering that the guidance and monitoring of patients remotely have become more frequent and necessary, the purpose of this protocol is to describe a clinical trial that will evaluate the impact of a pharmaceutical telecare service in aspects related to treatment adherence, disease control, and costs, offered to people with DM2 using dapagliflozin. The hypothesis that will be tested is that Pharmaceutical Telecare can be as effective as standard care for type 2 diabetes and assess the associated costs related to teleconsultation in public health settings.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05380596
Study type	Interventional
Source	Rio Grande do Sul State Health Department - SES/RS
Contact
Status	Not yet recruiting
Phase	N/A
Start date	June 1, 2022
Completion date	January 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03574480` - Smartphone Applications to Improve Lifestyles in Olders Over 65 Years	N/A
Not yet recruiting	`NCT04070066` - Educational Strategy IN Exchange Transfusion	N/A
Active, not recruiting	`NCT05043220` - Covid-19 Predictors: Safety of Gynecological Oncology Patients Undergoing Systemic Cancer Therapy	N/A
Recruiting	`NCT04045054` - Home-based Transitional Telecare for Older Veterans	N/A
Completed	`NCT04652674` - Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic	N/A
Completed	`NCT03295474` - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Recruiting	`NCT05480930` - Improving Nighttime Access to Care and Treatment; Part 4-Haiti	N/A
Completed	`NCT02196428` - Medical Telemonitoring Plus Individual Teleconsultation in Elderly	N/A
Completed	`NCT03025217` - Total Lifestyle Coaching Pilot Study (TLC)	N/A
Completed	`NCT01820234` - Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event	N/A
Recruiting	`NCT04392518` - Telerehabilitation in Proximal Muscle Weakness	N/A
Completed	`NCT05147038` - The Impact of Tele-coaching on the Physical Activity Level	N/A
Not yet recruiting	`NCT05897710` - Virtual World-Based Cardiac Rehabilitation	N/A
Not yet recruiting	`NCT04444297` - 3D Telemedicine During COVID-19: Non-clinical Validation	N/A
Not yet recruiting	`NCT04513496` - Telemedicine in HIV Care in Buenos Aires
Completed	`NCT05895539` - Evaluating Treatment Continuation in Telehealth Patients Receiving an Automated Patient-Reported Outcome Tool	N/A
Active, not recruiting	`NCT03474692` - Virta Health Registry
Recruiting	`NCT05046392` - mHealth Facilitated Intervention to Improve Medication Adherence Among Persons Living With HIV	N/A
Recruiting	`NCT05231018` - A Study on a Digital Platform for COVID19+ Patients, Designed to Facilitate Communication and Mental-health Care During and After Hospitalization.	N/A
Recruiting	`NCT05617560` - Hospital@Home: Telemedical Care After Inpatient Hospital Stay	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

TelePharmaceutical Care Diabetes Trial — TPCDT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms